#EliLilly's noncovalent BTK inhibitor #Jaypirca has been cleared by the #FDA in its first frontline indication for chronic lymphocytic leukaemia or small lymphocytic lymphoma (CLL/SLL).

pharmaphorum.com/news/lillys-...

FDA Expands Lilly's Jaypirca to First-Line CLL and SLL FDA approved Lilly's Jaypirca for certain previously untreated adults with CLL or SLL after a 282-patient Phase...

https://www.narrowit.com/news/fda-expands-lilly-jaypirca-first-line-cll-sll-2026-10-03
#EliLilly #Jaypirca #Pirtobrutinib #FDA

Eli Lilly's Jaypirca Receives FDA Approval for First-Line Treatment of CLL/SLL Patients #United_States #Indianapolis #CLL #Pirtobrutinib #Jaypirca

Innovent's Jaypirca® Receives Approval in China for CLL Treatment Across All Therapy Lines #China #Suzhou #CLL #Jaypirca #Innovent